Barclays Thinks Chemours Company’s Stock is Going to Recover


Barclays analyst Duffy Fischer maintained a Buy rating on Chemours Company (CC) on May 31 and set a price target of $42. The company’s shares closed on Friday at $21.09, close to its 52-week low of $21.08.

According to TipRanks.com, Fischer is a 4-star analyst with an average return of 8.7% and a 50.0% success rate. Fischer covers the Consumer Goods sector, focusing on stocks such as Air Products and Chemicals, Sherwin-Williams Company, and Venator Materials Plc.

Currently, the analyst consensus on Chemours Company is a Strong Buy with an average price target of $42.71.

See today’s analyst top recommended stocks >>

Based on Chemours Company’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $1.38 billion and net profit of $94 million. In comparison, last year the company earned revenue of $1.73 billion and had a net profit of $297 million.

Based on the recent corporate insider activity of 38 insiders, corporate insider sentiment is neutral on the stock. Most recently, in March 2019, Trojanowski Amy, the VP & Controller of CC sold 10,129 shares for a total of $396,044.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. It operates through the following segments: Titanium Technologies, Fluoroproducts, Chemical Solutions, and Corporate and Other. The Titanium Technologies segment produces titanium dioxide.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts